Navigation Links
Design of a new system that improves hearing in patients who carry a cochlear implant
Date:3/4/2008

This release is available in Spanish.

The doctoral thesis of Isaac Manuel lvarez Ruiz has been developed in the Departments of Department of Signal Theory, Telematics, and Communication, and Department of Surgery and its Specialties of the University of Granada, and directed by Professors ngel de la Torre Vega and Manuel Sainz Quevedo. The main aim of this work includes improving the acquisition of Compound Action Potential records, carrying out an application analysis in the cochlear implant programming and studying the distribution of refractory periods for the neuronal population that takes part in the generation of potentials. This doctoral thesis, carried out with the support of the Austrian company Med-El, is very useful for the manufacturers of cochlear implants as the results are a source of information for their present research lines.

The cochlear implant is an electronic device designed to help patients with severe and deep hypoacusis who get very little or no benefit from conventional hearing aids. Patients who use them can detect environmental sounds, most of them are able to understand language with no need of lip-reading, and some of them can even use the phone.

This device is composed of an inner part, implanted surgically, and an outer part. In the inner part we mainly find the stimulus generator and an electrodes-bearing guide inserted all along the cochlea. The outer part is mainly composed of a microphone, a voice processor and a battery unit. So, the signal received by the microphone can be analyzed by the voice processor, which determines the instant in which electrodes should be activated as well as the level of the stimulus.

Specifically

The voice processor in the implant should be specifically programmed for each patient. In order to do so, a programmer performs some subjective tests on the patient. Carrying out this task can get especially hard with children or non-cooperative patients, whose interaction with the programmer is limited or void. So, the search for an objective measurement which provides the automatic programming for the cochlear implant is one of the main research lines opened by the manufacturers. The Compound Action Potential is included in this aim.

The author of this work, Isaac Manuel lvarez Ruiz, states that the major difficulty in the recording and processing of the Compound Action Potential is the stimulation device, insomuch that the stimulation signal interferes in time and frequency with the recalled potential that is meant to be observed. In his thesis, an algorithm has been developed to allow an evaluation of the quality of a Compound Action Potential recording. This method lets us compare the most commonly used techniques in bibliography, as well as to develop new and improved techniques to reduce the stimulation device, points out the researcher.

The first task at the time of programming the cochlear implant is to decide which electrodes should be activated and subsequently, establish parameters for each one. So, this research has analyzed the relation between the Compound Action Potential and the cochlear implant voice processor programming map. We have found that the appearance of the potential generally involves the electrode connection and not vice versa. According to the parameters of each electrode, it has been found that the information provided by these potentials is insufficient for an automatic adjustment of the processor, in comparison with the results of our researches. Our results prove that the Compound Action Potential allows the establishment of parameters of each electrode regarding the average values of the patient, with acceptable uncertainty levels. This information could be very useful as complementary information, or when the subjective information from the patient is void.

Refractory periods

In addition, a study has been conducted about the distribution of refractory periods for the neuronal population that takes part in the generation of this potential. In the average patient, the value of the refractory period of the fastest neuron is about 0.8ms and half of the neurons have a refractory period lower than 1.5ms. It has been found that, as the auditory experience of the patient increases, the refractory period of the neurons that takes part in it decreases down to a stable value, that is reached 3-4 months after the start up of the voice processor.


'/>"/>

Contact: Isaac Manuel lvarez Ruiz
isamaru@ugr.es
34-626-186-403
Universidad de Granada
Source:Eurekalert

Related medicine news :

1. MSU engineering team designs innovative medical device
2. UCLA study identifies designer estrogen as potential MS drug
3. Implantable device designed to detect, stop seizures under study at MCG
4. Smith & Nephew Endoscopys KINSA(R) RC Suture Anchor Designed for Secure Repair of Rotator Cuff Injuries
5. Design Resource Extends Support for Orthopaedic and Cardiovascular Devices
6. Bullying Prevention Institute Designed to Empower Change in Schools
7. Smilebox and Lifetime Television Promote Breast Cancer Awareness With Multimedia Designs for Sending Mammogram Reminders and Celebrating Courage
8. Lafley Tells Shareholders That P&G is Designed to Grow
9. Independence Blue Cross Announces No Pay Getaway Promotion Designed to Encourage Healthy Behaviors
10. Fauquier Hospital - One of Only Five Nationwide to Receive Formal Designation as Patient-Centered Hospital
11. Regence Introduces Two New Plans Designed Especially for Small to Mid-Size Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 18, 2017 , ... A ... information and contact points to easily connect elderly veterans of America's armed forces ... elder-care funding. It also conveys material on this year's increase in the Veterans ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy Network offers physicians ... controlled and non-controlled substances plus the ability to manage orders on their desktop ... now accept electronic prescriptions, according to the Office of the National Coordinator of ...
(Date:2/17/2017)... ... 17, 2017 , ... Corrective Action & Preventive Action for ... Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/capamd      ... action (PA)? , The methods share techniques and tools but they are different ...
(Date:2/17/2017)... ... 17, 2017 , ... MAP Revenue Cycle Solutions (MAP RCS), ... been promoted to Chief Executive Officer. , The need for maximizing reimbursements ... that demands the transition from pay-for-service to pay-for-performance models. By delivering efficient and ...
(Date:2/17/2017)... ... February 17, 2017 , ... Like most hospitals across the nation, Onslow ... part by the Hospital Readmission Reduction Program (HRRP), the return of a patient to ... hospitals across the nation. While many providers are struggling to leverage limited resources and ...
Breaking Medicine News(10 mins):
(Date:2/19/2017)... , Feb. 19, 2017  nThrive™, an ... cycle portfolio and thought leadership at the 2017 ... a category leader award from KLAS. ... discussion focused on how market trends shape the ... particularly a sophisticated, comprehensive Patient Access solution. The ...
(Date:2/18/2017)... , Feb. 17, 2017  Pharmaceutical companies have long ... products either in development or already on the market.   ... the pharma industry to alter how it manages advisory board ... leader Best Practices, LLC conducted a new study focused on ... ...
(Date:2/17/2017)... , Feb. 17, 2017 Theravance ... Biopharma" or the "Company") today announced the presentation ... potent, and orally administered pan-Janus kinase (JAK) inhibitor ... th Congress of the European Crohn,s and ... Company reported further data from its completed Phase ...
Breaking Medicine Technology: